Immune recognition of transplacentally acquired lymphoid allografts selects for increased major histocompatibility polymorphism

Medical Hypotheses

Volumn 77, Issue 3, 2011, Pages 323-325

  Naugler, Christopher ^a  

^a CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLELE; ALLOGRAFT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; GENETIC POLYMORPHISM; HUMAN; IMMUNOSURVEILLANCE; INCIDENCE; LYMPHOID CELL; MICROCHIMERISM; NATURAL SELECTION; PREGNANCY;

ALLELES; ANTIGEN PRESENTATION; BIOLOGICAL EVOLUTION; FEMALE; HUMANS; LYMPHOCYTES; MAJOR HISTOCOMPATIBILITY COMPLEX; MATERNAL-FETAL EXCHANGE; POLYMORPHISM, GENETIC; PREGNANCY; SELECTION, GENETIC;

MAMMALIA;

EID: 80051828492     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.05.005     Document Type: Article

References (53)

1. Kaufman J. Evolution and immunity. Immunology 2010, 130:459-462.
2. Kumanovics A., Tokada T., Lindahl K.F. Genomic organization of the mammalian MHC. Annu Rev Immunol 2003, 21:629-657.
3. Kaufman J., Milne S., Gobel T.W., Walker B.A., Jacob J.P., et al. The chicken B locus is a minimal essential major histocompatibility complex. Nature 1999, 410:923-925.
4. Sidney J., Peters B., Frahm N., Brander C., Sette A. HLA Class I supertypes: a revised and updated classification. BMC Immunol 2008, 9:1.
5. Naugler C.T. Origins and relatedness of human leukocyte antigen Class I allele supertypes. Hum Immunol 2010, 71:837-842.
6. Solomon C., Southwood S., Hoof I., Rudersdorf R., Peters B., Sidney J., et al. The most common Chinese rhesus macaque MHC Class I molecule shares peptide binding repertoire with the HLA-B7 supertype. Immunogenetics 2010, 62:451-464.
7. Schwensow N., Fietz J., Dausmann K.H., Sommer S. Neutral versus adaptive genetic variation in parasite resistance. importance of major histocompatibility complex supertypes in a free-ranging primate. Heredity 2007, 99:265-277.
8. Lavender K.J., Kane K.P. Cross-species dependence of Ly49 recognition on the supertype defining B-pocket of a Class I MHC molecule. J Immunol 2006, 177:8578-8586.
9. Sidney J., Asabe S., Peters B., Purton K.A., Chung J., Pencille T.J., et al. Detailed characterization of the peptide binding specificity of five common Patr Class I MHC molecules. Immunogenetics 2006, 58:559-570.
10. Apanius V., Penn D., Slev P.R., Ruff L.R., Potts W.K. The nature of selection on the major histocompatibility complex. Crit Rev Immunol 1997, 17:179-224.
11. Grob B., Knapp L.A., Martin R.D., Anzenberger G. The major histocompatibility complex and mate choice. inbreeding avoidance and selection of good genes. Exp Clin Immunogenet 1998, 15:119-129.
12. Borghans J.A.M., Beltman J.B., De Boer R.J. MHC polymorphism under host-pathogen coevolution. Immunogenetics 2004, 55:732-739.
13. Penn D.J., Damjanovich K., Potts W.K. MHC heterozygosity confers a selective advantage against multiple-strain infections. PNAS 2002, 99:11260-11264.
14. Houghes A.L., Nie M. Pattern of nucleotide substitution at major histocompatibility Class I loci reveals overdominant selection. Nature 1988, 335:167-170.
15. Houghes A.L., Nie M. Nucleotide substitution at major histocompatibility Class II loci: evidence for overdominant selection. PNAS 1989, 86:958-962.
16. Gonen-Gross T., Goldman-Wohl D., Huppertz B., Lankry D., Greenfield C., Natanson-Yaron S., et al. Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface. PLoS ONE 2010, 5:e8941.
17. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003, 171:1376-1384.
18. Hunt J.S., Orr H.T. HLA and maternal-fetal recognition. FASEB J 1992, 6:2344-2348.
19. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosells E.O. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uternine natural killer cytolysis. PNAS 1977, 94:11520-11525.
20. Miech R.P. The role of fetal microchimerism in autoimmune disease. Int J Clin Exp Med 2010, 3:164-168.
21. Berry S.M., Hassan S.S., Russell E., Kukuruga D., Land S., Kaplan J. Class II HLA loci with maternal microchimerism in the fetus. Pediatr Res 2004, 56:73-78.
22. Scaradavou A., Carrier C., Mollen N., Stevens C., Rubinsteinn P. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996, 88:1494-1500.
23. Petit T., Dommergues M., Socie G., Dumez Y., GLuckman E., Brison O. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 1997, 98:967-971.
24. Klonisch T., Drouin R. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Med 2009, 15:510-518.
25. Bianchi D., et al. Male fetal progenitor cells persist in maternal blood as long as 27 years postpartum. PNAS 1995, 93:705-708.
26. Maloney S., et al. Microchimerism of maternal origin persist into adult life. J Clin Invest 1999, 104:41-47.
27. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.C. Long term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
28. Pollack M.S., Kirkpatrick D., Kapoor N., Dupent B., O'Reilly R.J. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982, 307:662.
29. Barrett M.J., Buckley R.H., Schiff S.E., Kidd P.C., Ward F.E. Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism. Clin Exp Immunol 1988, 72:118-123.
30. Schroeder M.L. Transfusion-associated graft-versus-host disease. Br J Haematol 2002, 117:275-287.
31. Ohto H., Anderson K.C. Post transfusion-associated graft-versus-host disease in Japanese newborns. Transfusion 1996, 36:117-123.
32. Nelson J.L., Gillespie K.M., Lambert N.C., Stevens A.M., Loubiere L.S., Rutledge J.C., et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet cell microchimerism. PNAS 2007, 104:1637-1642.
33. Abbud Filho M., et al. Systemic lupus erythematosus and microchimerism in autoimmunity. Transplant Proc 2002, 34:2951-2952.
34. Klintschar M., Immel U.D., Kehlen A., Schwaiger P., Mustafa T., Mannweiler S., et al. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol 2006, 154:237-241.
35. Ando T., Davies T.F. Clinical review 160: postpartum autoimmune thyroid disease: the potential role of fetal microchimerism. J Clin Endocrinol Metab 2003, 88:2965-2971.
36. Artlett C.M., Welsh K.I., Black C.M., Jimenez S.A. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997, 47:17-22.
37. Hromadnikova I., Zlacka D., Hein Nguyen T.T., Sedlackova L., Zejskova L., Sosna A. Fetal cells of mesenchymal origin in cultures derived from synovial tissue and skin of patients with rheumatoid arthritis. Joint Bone Spine 2008, 75:563-566.
38. Fanning P.A., et al. Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol 2000, 33:690-695.
39. Vabres P., et al. Microchimerism from a dizygotic twin in juvenile ulcerative lichen planus. Lancet 2002, 359:1861-1862.
40. Endo Y., et al. Possible contribution of microchimerism to the pathogenesis of Sjogren's syndrome. Rheumatology (Oxford) 2002, 41:490-495.
41. van Rood J.J., Claas F. Both self and non-inherited maternal HLA antigens influence the immune response. Immunol Today 2000, 21:269-273.
42. King C.L., Malhotra I., Mungai P., Wamachi A., Kioko J., Ouma J.H., et al. B cell sensitization to helminthic infection develops in utero in humans. J Immunol 1998, 160:3578-3584.
43. Aase L.M., Noren G.R., Reddy D.V., St Gene J.W. Mumps-virus infection in pregnant women and the immunogenic response of their offspring. N Engl J Med 1972, 286:1379.
44. Hara T., Ohashi S., Yamashita T., Abe T., Hisaeda H., Himeno K., et al. Human Vδ2+ γδ T-cell tolerance to foreign antigens of toxoplasma gondii. Proc Natl Acad Sci U S A 1996, 93:5136.
45. Gill T.J., Repetti C.F., Metlay L.A., Rabin B.S., Taylor F.H., Thompson D.S., et al. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983, 72:987-996.
46. Baker C.J., Rench M.A., Edwards M.S., Carpenter R.J., Hays B.M., Kasper D.L. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988, 319:1180.
47. McCormick J.B., Gusmao H.H., Nakamura S., Freire J.B., Veras J., Gorman G., et al. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. J Clin Invest 1980, 65:1141.
48. Endres RO, Kleinman SH, Carrick DM, Steele WR, Wright DJ, Norris RJ, Triulzi D, Kakaiya R, Bausch MP. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion 2010 [epub ahead of print].
49. Triulzi D.J., Kleinman S., Kakaiya R.M., Busch M.P., Norris P.J., Steele W.B., et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009, 49:1825-1835.
50. Belov K., Deakin J.E., Papenfuss A.T., Baker M.L., Melman S.D., Siddle H.V., et al. Reconstructing an ancestral mammalian immune supercomplex from a marsupial major histocompatibility complex. PLoS Biol 2006, 4:e46.
51. Holden B.A., Greville W.D., Sherwin W.B. Evolution of MHC Class I loci in marsupials: characterization of sequences from Koala (Phascolarctos cinereus). Mol Biol Evol 1996, 13:1119-1127.
52. Kaplan J., Land S. Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism. J Immunol 2005, 174:7123-7128.
53. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol 1993, 68:495-532.